Susquehanna Fundamental Investments LLC Buys Shares of 52,424 Select Medical Holdings Co. (NYSE:SEM)

Susquehanna Fundamental Investments LLC purchased a new position in shares of Select Medical Holdings Co. (NYSE:SEM) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 52,424 shares of the health services provider’s stock, valued at approximately $988,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Barclays PLC raised its stake in shares of Select Medical by 396.0% in the 3rd quarter. Barclays PLC now owns 192,357 shares of the health services provider’s stock valued at $6,707,000 after purchasing an additional 153,576 shares in the last quarter. Virtu Financial LLC acquired a new stake in Select Medical during the third quarter valued at approximately $210,000. Wilmington Savings Fund Society FSB bought a new position in Select Medical during the 3rd quarter worth approximately $81,000. Tidal Investments LLC bought a new stake in shares of Select Medical in the 3rd quarter valued at approximately $286,000. Finally, Franklin Resources Inc. raised its position in shares of Select Medical by 12.0% during the 3rd quarter. Franklin Resources Inc. now owns 69,448 shares of the health services provider’s stock valued at $2,354,000 after acquiring an additional 7,441 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Trading Down 0.2 %

Shares of SEM stock opened at $18.20 on Friday. The firm has a market capitalization of $2.35 billion, a PE ratio of 11.03, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical Holdings Co. has a 1 year low of $14.99 and a 1 year high of $40.98. The stock has a fifty day moving average of $17.01 and a two-hundred day moving average of $21.96.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.01). The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The business’s quarterly revenue was down 24.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 EPS. As a group, research analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a yield of 1.37%. Select Medical’s payout ratio is currently 15.15%.

Select Medical declared that its Board of Directors has initiated a stock buyback program on Thursday, May 1st that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to buy up to 42.6% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity

In related news, CEO David S. Chernow sold 225,000 shares of the firm’s stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the transaction, the chief executive officer now owns 714,516 shares of the company’s stock, valued at $12,861,288. This trade represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 11.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have weighed in on SEM shares. Mizuho assumed coverage on shares of Select Medical in a report on Wednesday, April 16th. They set an “outperform” rating and a $25.00 target price on the stock. UBS Group reduced their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research report on Monday, February 24th. Finally, Royal Bank of Canada cut their price objective on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research report on Monday, February 24th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $26.80.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.